
1 

(1) These Regulations may be cited as the Branded Health Service Medicines (Costs) (Amendment) Regulations 2022 and come into force on 1st July 2022.
(2) These Regulations extend to England and Wales, Scotland and Northern Ireland.
2 

(1) The Branded Health Service Medicines (Costs) Regulations 2018 are amended as follows.
(2) In regulation 3 (payment scheme)—
(a) in paragraph (1), for the table substitute the following table—“

Applicable Period Payment Percentage
1st July 2022 to the end of 2022 14.3%
2023 and any subsequent calendar year 24.4%”;
(b) in paragraph (1B)—
(i) for “1st April 2020 to the end of 2020” substitute “1st July 2022 to the end of 2022”;
(ii) for “5.0%” substitute “17.7%”, and
(iii) for “7.4%” substitute “14.3%”; and
(c) in paragraph (1C)—
(i) for “1st April 2020 to the end of 2020” substitute “1st July 2022 to the end of 2022”;
(ii) in sub-paragraph (a)—(aa) for “1st January 2020” substitute “1st January 2022”, and(bb) for “31st March 2020” substitute “30th June 2022”, and
(iii) in sub-paragraph (b), for “14.7%” substitute “10.9%”.
Signed by the authority of the Secretary of State for Health and Social CareKamall
Parliamentary Under-Secretary of State,
Department of Health and Social Care
26th May 2022